Clinical Trial Update: To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period [NA]

View source ↗

Summary

A clinical trial update indicating that recruitment is ongoing (enrolling by invitation) for adults with Type 1 or Type 2 diabetes to evaluate changes in glucos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• iCan o3 CGM System

Snippet

Sponsor: Sinocare | Conditions: Diabetes Mellitus, Continuous Glucose Monitoring System | NA | Status: ENROLLING_BY_INVITATION